ALLR Earnings Allarity Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–13 of 13
| Q2 2024 | 2024-06-30 | -0.73 | 2024-08-05 | 10-Q |
| Q1 2024 | 2024-03-31 | -22.14 | 2024-05-14 | 10-Q |
| FY 2023 | 2023-12-31 | -10.26 | 2024-03-08 | 10-K |
| Q3 2023 | 2023-09-30 | -18.84 | 2023-11-14 | 10-Q |
| Q2 2024 | 2023-06-30 | -1336.40 | 2024-08-05 | 10-Q |
| Q1 2024 | 2023-03-31 | -6356.06 | 2024-05-14 | 10-Q |
| FY 2023 | 2022-12-31 | -3093.42 | 2024-03-08 | 10-K |
| Q3 2023 | 2022-09-30 | -2733.21 | 2023-11-14 | 10-Q |
| Q2 2023 | 2022-06-30 | -97.63 | 2023-08-14 | 10-Q |
| Q1 2023 | 2022-03-31 | -19.64 | 2023-05-11 | 10-Q |
| FY 2022 | 2021-12-31 | -4.19 | 2023-03-13 | 10-K |
| Q3 2022 | 2021-09-30 | -1.70 | 2022-11-14 | 10-Q |
| Q2 2022 | 2021-06-30 | -1.78 | 2022-10-07 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.